This inventor holds 2 USPTO granted patents. Top assignee: Ochsner Clinic Foundation. Active years: 2004-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2026
Title: Innovations of Li Li in Monoclonal Antibodies
Introduction
Li Li is an accomplished inventor based in New Orleans, LA. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions for treating various medical conditions, including cancers and autoimmune diseases.
Latest Patents
Li Li holds a patent for monoclonal antibodies that suppress B cell growth and/or differentiation. The present invention provides monoclonal antibodies that interfere with the interactions between follicular dendritic cells (FDCs) and B cells. This interference effectively suppresses the proliferation and/or differentiation of B cells in lymphoid follicles. The monoclonal antibodies developed by Li Li are particularly useful for treating follicular lymphomas, multiple myeloma, and autoimmune diseases. He has 1 patent to his name.
Career Highlights
Li Li is currently associated with the Ochsner Clinic Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on therapeutic strategies in oncology and immunology.
Collaborations
Li Li collaborates with various professionals in his field, including his coworker, Yong Sung Choi, who brings valuable expertise to their joint efforts.
Conclusion
Li Li's innovative work in monoclonal antibodies represents a significant advancement in medical science. His contributions have the potential to improve treatment options for patients suffering from serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile